Panel Endorses STAN Fetal Monitor, Emphasizes Need For Clinician Education
This article was originally published in The Gray Sheet
Executive Summary
FDA's Obstetrics & Gynecology Devices Panel unanimously (9-0) recommended conditional approval for Neoventa Medical's STAN fetal heart monitoring system during a June 23 meeting in Gaithersburg, Md